LWAC
PACB icon

Laurel Wealth Advisors (California)’s Pacific Biosciences PACB Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,243
Closed -$230K – 723
2022
Q1 		$230K Hold
25,243
– – 0.02% 674
2021
Q4 		$516K Sell
25,243
-60
-0.2% -$1.45K 0.04% 442
2021
Q3 		$646K Hold
25,303
– – 0.12% 201
2021
Q2 		$885K Buy
25,303
+176
+0.7% +$5.12K 0.11% 190
2021
Q1 		$837K Buy
25,127
+127
+0.5% +$4.45K 0.13% 177
2020
Q4 		$649K Sell
25,000
-200
-0.8% -$3.4K 0.1% 202
2020
Q3 		$249K Buy
+25,200
New +$145K 0.04% 336
2019
Q2 		– Sell
-26,000
Closed -$188K – 424
2019
Q1 		$188K Buy
+26,000
New +$188K 0.05% 369

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return